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Abstract
Spontaneous disease extinction can occur due to a rare stochastic fluctuation. We explore this process, both numerically
and theoretically, in two minimal models of stochastic viral infection dynamics. We propose a method that reduces the
complexity in models of viral infections so that the remaining dynamics can be studied by previously developed techniques
for analyzing epidemiological models. Using this technique, we obtain an expression for the infection clearance time as a
function of kinetic parameters. We apply our theoretical results to study stochastic infection clearance for specific stages of
HIV and HCV dynamics. Our results show that the typical time for stochastic clearance of a viral infection increases
exponentially with the size of the population, but infection still can be cleared spontaneously within a reasonable time
interval in a certain population of cells. We also show that the clearance time is exponentially sensitive to the viral decay rate
and viral infectivity but only linearly dependent on the lifetime of an infected cell. This suggests that if standard drug
therapy fails to clear an infection then intensifying therapy by adding a drug that reduces the rate of cell infection rather
than immune modulators that hasten infected cell death may be more useful in ultimately clearing remaining pockets of
infection.
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Introduction
Deterministic models of viral infection have been successful in
fitting experimental data and extracting useful parameter values
[1,2,3,4]. Such models are based on a large population of infected
cells and virions, so they fail to capture some important stages of
viral infection dynamics for which intrinsic stochastic effects play a
dominant role. One of the remarkable phenomena observed in
stochastic population dynamics is spontaneous extinction of a
disease via a rare fluctuation. Small population sizes or heteroge-
neity in populations are some of the determining factors for
extinction to occur. A major characteristic of disease extinction is
the extinction time - the mean time in which the number of infected
cells reaches zero. An estimate of the time required for the infection
to be cleared can be tested during drug treatment on a patient.
The theory of disease extinction should identify parameters that
are most important for determining the extinction time, and hence
suggest processes that one might want to target by drug therapy to
decrease the extinction time. For example, recent experimental
work [5] has proposed a method that predicts the location, timing
and magnitude of the immune response needed for a vaccine to
eliminate persistent infection in the early stages of viral infection.
Models that describe spontaneous virus extinction can be
relevant to various stages of a viral infection. Up to one third of
patients with acute hepatitis C virus (HCV) infection spontane-
ously clear the infection [6]. Because HCV levels reach a plateau
or steady-state level within the first week to two of infection [7], it
is likely that patients who spontaneously clear do so from a steady
state. Spontaneous clearance of HCV infection can take place in
the presence of HCV specific immune responses [8,9]. There has
also been a report on chimpanzees demonstrating the clearance of
HCV infection spontaneously in the absence of a detectable
immune response [10]. More recent studies demonstrate the
clearance of low levels of HCV in humans in the absence of HCV
specific cellular immune responses [11]. These results suggest that
a small population of infected cells in the human liver can be
cleared spontaneously even in the absence of drug therapy or an
immune response. Under drug treatment, a drug may not be
delivered equally well to all infected regions in the body, as
reported for HIV-1 infection [12,13]. Thus, there may be regions
with a small number of infected cells in which drug levels are low
so that stochastic extinction of virus and infected cells may be the
major recovery mechanism in those regions. Spontaneous disease
extinction can also occur during HIV infection propagation at
early stages of the disease. Before entering the blood stream, a
sexually transmitted virus, such as HIV, has to diffuse through the
tissue in the genital tract where it experiences a scarce supply of
susceptible cells and spatial confinement in a strongly heteroge-
neous medium [14]. In such a situation, the infection may enter a
quasi-steady state locally. This state is characterized by a balance
between the rate of virus decay and replication. Spontaneous
infection clearance may take place from such a quasi-steady state.
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38549In the context of HIV or HCV infection, we will assume that the
total number of infected cells in the considered region, nI,i s
relatively small and fluctuates with time so that the size of a typical
fluctuation is of the order of , nI
1/2. In the context of HCV
infection, we will use kinetic parameters estimated in Rong et al.
[27], while for HIV we use parameters discussed by Pearson et al.
[15]. Since an infection can go extinct only due to a rare event,
spontaneous infection clearance is described by the tails of the
infected cell number probability distribution. With these assump-
tions we estimate that the critical population size for spontaneous
clearance of HIV infection is of the order of nI ,10 cells. Our
estimates of the critical population size in infection with kinetic
parameters of HCV demonstrate that when the number of
infected cells in a region is about 40 or less, then spontaneous
clearance would take place during a year.
A theoretical approach to compute fluctuation induced disease
extinction time for non-viral infections was developed recently
based on the so-called semi-classical path integral technique
[16,17,18]. This method has been successfully applied to several
stochastic epidemiological models such as the endemic susceptible
– infected - recovered (SIR), and SI models [19], and the endemic
SIS model [18] to determine the mean extinction time of a disease.
Despite the success in epidemic models, the semi-classical
method has not been applied to viral infections. This can be
explained partly by the relative complexity of stochastic models
that involve both virus particles and infected/susceptible cells. One
of our goals in this manuscript is to show that the complexity of
viral infection dynamics can be effectively reduced in the semi-
classical approach using a coarse-graining technique developed
recently [20,21]. We will show that coarse-graining typically
reduces the models of viral infections to some of the previously
studied types of stochastic SI models.
Before we discuss a general model of interactions between
viruses and infected/susceptible cells, we explore in some detail
two minimal stochastic models of early infection that were partly
explored recently by Pearson et al. [15]. They studied the
extinction probability with the assumption that the infection starts
from a given number of virions and infected cells that are
introduced into a body in which an extremely large number of
cells are susceptible to infection; the question of spontaneous
infection clearance from an endemic state was not considered.
Stochastic simulations of HIV and SIV infection, performed
earlier [22,23,24], show that during early infection, the number of
virions and infected cells either both reach zero implying
extinction or they both eventually reach constant quasi-steady
state values at which the infection is maintained. Our semi-
classical technique complements the study by Pearson et al. [15]
by allowing us to consider more complex behavior such as
infection extinction from a metastable state.
Methods
Models of Viral Infection
We will concentrate on the two models studied by Pearson et al.
[15], the continuous virus production model (Model 1) and the
burst model of viral production (Model 2); however, our approach
can be easily extended to arbitrary systems. As in Pearson et al.
[15], we assume all virions are equivalent and equally infectious
and thus ignore non-infectious or defective virus particles. As
discussed by Pearson et al. [15], it is not known whether viral
production in HIV occurs in a burst or is continuous. Burst
production may be a reasonable approximation for viral
production from activated T cells, while continuous production
may be more relevant for production from resting T cells or
macrophages. Since HCV infection generally does not kill the cells
it infects [25], production of HCV is most likely continuous.
Model 1 (Continuous viral production). The kinetics of
Model 1 is explained in Figure 1(a). Virus, V, can infect susceptible
cells, T, with rate constant k, VzT  ?
k
I. We neglect variations
in the number of target cells and hence this reaction can be written
as V  ?
kT
I. During its lifetime, an infected cell, I, continuously
produces virus particles with rate Nd, where N is the total number
of infectious viral particles produced by a cell during its lifespan
and 1=d is the average lifespan of an infected cell. Virus particles
are cleared and infected cells die, respectively, with rates c and d.
Model 2 (Burst model). Some viruses, rather than being
produced continuously by an infected cell, leave the cell in a large
burst that usually kills the cell as they exit. The kinetics of this
model is explained in Figure 1(d). Once an infected cell dies, it
releases N..1 virions in a single burst. The deterministic
equations for the burst model (Model 2) and the continuous
production model (Model 1) are identical. However, Pearson et al.
[15] showed that the stochastic effects in these two models are
different. Our coarse-graining approach will explain and quantify
this observation naturally.
Initially we assume that the number of susceptible cells is much
larger than the number of infected cells. In this case, we can neglect
variations in the number of target cells and assume that kT is a
constant. This is the case that was previously considered by Pearson
et al.[15].Wewillexploreitinthepresentworkaswellbutthistime
we will use our new semiclassical coarse-graining approach.
At later stages of the infection, virus may infect many of the
available susceptible cells and reach an equilibrium metastable
state. This equilibrium depends on how new susceptible cells are
produced or diffuse into the region of interest. Here we will
consider a few examples by assuming that the total number of cells
is kept constant, Nt, so that nI=N t –n T,. where nI and nT are the
numbers of infected and target cells, i.e., cells susceptible to
infection, respectively.
The assumption of a constant total number of cells has been
made in models of hepatitis B virus (HBV) and hepatitis C virus
(HCV) infection of the liver [26,27]. The liver is known to
regenerate if it is damaged and a homeostatic process returns the
liver to its original size. In HIV infection total CD4+ T cell
numbers are not maintained constant over the disease course.
However, since T cell depletion occurs on a time scale of years,
with the T cell count on average falling from 1000/1000=mL to
200=mL over about 10 years. Thus, over shorter periods, say days
to months, the CD4+ T cell level is relatively constant in the
chronic stage of disease. Thus, this approximation may be valid in
such circumstances. We will explore the case in which the total cell
population is held constant in the present work and use our
semiclassical coarse-graining approach to calculate the probability
to escape from this metastable state.
We will use the mean field assumption that in the considered
region all uninfected cells are equally susceptible to infection by all
virions. This assumption, however, does not restrict us in choosing
a dependence of the viral infection rate kT on the total number of
cells Nt, in the region of interest. There are two types of
dependence, which emerge from different conditions. The first
corresponds to a linear dependence of kT on the number of
susceptible cells, i.e., kT~k0
1(Nt{nI), where k0
1 is a constant.
This scaling is expected in a region where the law of mass-action
should hold, i.e., a region that is well-mixed with fixed spatial
dimensions and mobile susceptible cells and virions. Hence, we
will discuss it in the context of HIV infection, in which virions and
susceptible cells are assumed to be trapped in a finite region from
which they are unlikely to escape. We note that the parameter k0
1
Spontaneous Infection Clearance
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1(Nt{nI) is an effective parameter that depends on the
spatial dimensions of the considered region, since in a mass-action
context k0
1 would be multiplied by a cell density, i.e. (Nt{nI)
would be divided by the volume of the region and similarly k0
1
would implicitly need to be multiplied by this same volume. Since
experimental data on infection kinetics within a region of known
volume are not presently available, for demonstration of our
method, we will use effective parameters that were previously used
by Pearson et al. [15] in their studies of the early HIV infection.
Another scaling emerges when the region of interest contains a
dense population of immobile cells, so that the spatial dimensions
of the region increase with Nt. In this case the probability of any
given susceptible cell to be infected by a given virion decreases
inversely proportional to Nt. In such a case, we will assume
kT~k0
1
Nt{nI
Nt
: We will consider this type of scaling during our
discussion of HCV infection of cells in the liver. Here we note that
in this case, the parameter k0
1 has a clear physical interpretation; it
is the rate of collision of a virion with cells during the virion
diffusion multiplied by the probability that upon collision with a
susceptible cell that cell becomes infected. Because we assume k0
1 is
constant, i.e. the virus collides with cells at a constant rate, the size
of the region under consideration must be small. As we shall show,
the value of k0
1 do not depend on the spatial dimensions of the
considered region, and hence estimates of this parameter can be
obtained from clinical data about average virus kinetics. Thus, our
calculations in this second case can be performed completely using
only known facts about average kinetics of HCV infection.
Deterministic Scenario
Before considering stochastic effects, we note that the
deterministic equations for the concentration of virus, V, and
infected cells, I, in Model 1 can be written in the following form:
dV
dt
~{ kTzc ðÞ VzNdI
dI
dt
~{dIzkTV
ð1Þ
Figure 2(a) shows the evolution of the number of infected cells at
constant kinetic rates using Gillespie’s stochastic simulation method
[28]. We use the following parameter values kT =10 day
21, c=20
day
21, d=1 day
21, previously used by Pearson et al. [15] in their
numerical simulations of HIV dynamics during the initial stage of
infection, but set N=30. The actual number of infectious virions
released during chronic infection is not known. Chen et al. [29]
estimate that in SIV infection about 50,000 SIV particles are
released,butthe fractionthat areinfectioushas been estimatedtobe
between 1 in 1,000 to 1 in 10,000, suggesting that N should lie
between 5 and 50 [15]. However, recent estimates of the basic
reproductive number, R0, for HIV suggest each infected cell infects
about 10 others [30], and N would necessarily have to be 10 or
larger, and thus we have set N=30. In these simulations, the
number of infected cells grows exponentially with time. Figure 2(b)
shows that if the depletion of susceptible cells is taken into account
(see Text S3), so that kT is no longer constant, kT~k’1 Nt{nI ðÞ ,
the number of infected cells reaches a steady state.
Fluctuations
The dynamics of a stochastic system can be described by the
birth- death master equation for the transition probabilities. For
Model 1, the master equation for the probability of having nV
viruses and nI infected cells at time t is given by
Figure 1. Schematic representation of viral infection models, (a) Model 1 (b) Comparison with simple SIS model (c) Comparison of
effective Hamiltonians for both these models (d) Model 2 (e) Comparison with simple SI model (f) effective Hamiltonian for both
these models.
doi:10.1371/journal.pone.0038549.g001
Spontaneous Infection Clearance
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38549LPn V,nI,t ðÞ
Lt
~ kTzc ðÞ nVz1 ðÞ Pn Vz1,nI,t ðÞ {nVPn V,nI,t ðÞ ½ 
zNdnI Pn V{1,nI,t ðÞ {Pn V,nI,t ðÞ ½ 
zd nIz1 ðÞ Pn V,nIz1,t ðÞ {nIPn V,nI,t ðÞ ½ 
zkTnV Pn V,nI{1,t ðÞ {Pn V,nI,t ðÞ ½  ,
ð2Þ
and for Model 2 the master equation is given by
LPn V,nI,t ðÞ
Lt
~ kTzc ðÞ nVz1 ðÞ Pn Vz1,nI,t ðÞ {nVPn V,nI,t ðÞ ½ 
zdnI Pn V{N,nI,t ðÞ {Pn V,nI,t ðÞ ½ 
zd nIz1 ðÞ Pn V,nIz1,t ðÞ {nIPn V,nI,t ðÞ ½ 
zkTnV Pn V,nI{1,t ðÞ {Pn V,nI,t ðÞ ½  :
ð3Þ
Solving these master equations would provide a complete
description of the time evolution of the stochastic system, but in
general it is impossible to obtain explicit solutions for the master
equation.
Semi-classical Treatment of the System’s Dynamics
For our models, it is impossible to get a closed form solution for
master equations, and reasonable approximations are needed.
Here we will employ an eikonal approximation to recast the
problem in terms of an effective classical Hamiltonian system. This
semi-classical method can be applied to simplify analysis of
fluctuations, including rare event statistics, when the number of
interacting objects is relatively large. This method has been used
earlier to calculate the rare event statistics in reaction diffusion
systems [16] and it has been applied to various epidemiological
stochastic models (SI, SIS, SIR) as examples [18,19].
Our goal is to find the generating function,
G(xC,t)~
P ?
n~0
exC
:nP(n,t), where n is the vector of populations.
Components of this vector are numbers of agents (i.e. virus
particles, infected cells) of each type participating in a process. For
example, in our modelsn~(nV,nI), where nV is the number of
virions and nI is the number of infected cells. Note that with every
vector of populations, we associate a vector of conjugated
variables, xC. In our models, xC~(xC,V,xC,I). Knowledge of the
generating function provides information about all measurable
characteristics, including the extinction probability.
The master equation can be transformed into a Schro ¨dinger-
like equation for the evolution of G with effective quantum
Hamiltonian, ^ H H[16].
LG
Lt
~^ H HG ð4Þ
Here we do not provide the derivation of the semi-classical
approach and refer the reader to Text S1 as well as original
reviews and publications [16,18,31]. We only summarize the
procedure for obtaining the generating function by this technique:
1.The method starts with using the eikonal ansatz
G(xC,t)~e{S(xC,t):
2. By considering the trajectories that dominate the dynamics, it
was found that S(xC,t) is given by
S xC,t ðÞ ~
ð
tf
0
_ x xnzHn ,x ðÞ ðÞ dt, ð5Þ
where x tf
  
~xC and the function H, which we will call the
Hamiltonian, is obtained as follows:
Figure 2. The number of infected cells nI versus time t, for Model 1 with multiple stochastic runs (a) kT= constant, (b)
kT~k0
1(Nt{nI). nI (0)=0, nV (0)=10, kT =10 day
21, N=30, c=20 day
21, d=1 day
21, Nt=1000, andk’1 =0.01 day
21.
doi:10.1371/journal.pone.0038549.g002
Spontaneous Infection Clearance
PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e38549Every elementary reaction contributes a specific term to H. For
example, if a reaction corresponds just to a creation of particles
with time according to a Poisson distribution, PP
n~
(kt)
ne{kt
n!
,
then a corresponding term in the Hamiltonian is
HP x ðÞ ~ke x{1 ðÞ . There are other rules that we will need in this
article [20,21,31]:
2a) Let us consider a reaction describing a Poisson process of
conversion of particles of the type A into particles of the type B
given by.
mAA  ?
k
mBB, ð6Þ
with some rate, k, which may depend on the number of all types
of particles in the reaction diffusion system. The corresponding
term in the Hamiltonian is given by.
H~ke mBxB{mAxA{1 ðÞ , ð7Þ
where xA and xB are conjugate variables to A and B. A detailed
derivation of Eq. (7) via a stochastic path integral approach is
provided in Text S1.
2b) When mB is not a constant, but some random variable with a
distribution P(mB), then exB in Eq. (7) is replaced by
z xB ðÞ ~
P
mB
exBmBPm B ðÞ :
The latter rule follows from the fact that the Hamiltonian can be
derived from the form of the generating function, Z x,t ðÞ , of the
given reaction at constant parameters [20,21], i.e.
Z x,t ðÞ :
P
n
Pn t ðÞ enx~eH x ðÞ t. That is, if we find Z(x,t) with an
assumption that concentrations of particles are constant, we can
identify the Hamiltonian of the reaction. A Poisson process that
creates bursts of particles, with rate k and with each burst
described by the function z xB ðÞ defined in the rule 2b), has the
generating function Z x ðÞ :
P
n
PP
nz x ðÞ
n~eHP z x ðÞ ðÞ t~ekt z x ðÞ {1 ½  .
More rules about constructing terms in the Hamiltonian that
correspond to various types of reactions can be found in earlier
publications [20,21,31].
3.Vectors, n(t) and x t ðÞin Eq. (5), are obtained by solving the
Hamiltonian equations.
_ n n~
LH
Lx
, _ x x~{
LH
Ln
ð8Þ
with boundary conditions, nt ~0 ðÞ ~n 0 ðÞand x tf
  
~xC.W e
can then substitute the solutions of Eq. (8) into Eq. (5) to obtain the
generating function.
Following the above rules, (Eq. (6–7)) and examination of each
term in Model 1, the Hamiltonian is given by.
H1~kTnV exI{xV{1 ðÞ zdNnI exV{1 ðÞ
zcnV e{x
V{1 ðÞ zdnI e{x
I{1 ðÞ ,
ð9Þ
where there are four terms corresponding to each elementary
reaction in Figure 1(a).
For Model 2 (burst model of virus production), the Hamiltonian
is the sum of three terms.
H2~kTnV exI{xV{1 ðÞ zdnI eNxV{xI{1
  
zcnV e{x
V{1 ðÞ
ð10Þ
The latter Hamiltonian, H2, was derived assuming that number
of viruses produced per infected cell is a constant. Following the
rules described in 2b), if N is the mean of a Poisson distributed
number of produced viruses, the Hamiltonian for Model 2 should
rather be written as.
H2~kTnV exI{xV{1 ðÞ zdnI eeN xV{1 ðÞ {xI{1
  
zcnV e{x
V{1 ðÞ
ð11Þ
Note that the second term in H2 follows from the rule 2b), where
z xV ðÞ ~eN(e
xV {1) is the generating function of Poisson distributed
virus particles with mean N. Hamiltonian equations of motion in
both cases are given by.
_ n nI~
LH
LxI
, _ n nV~
LH
LxV
_ x xI~{
LH
LnI
, _ x xV~{
LH
LnV
ð12Þ
Results
Coarse-Graining
Equations. (9), (11) and (12) are a substantial simplification
compared to the master equation because they are a set of a few
ordinary differential equations in comparison to master equation,
which is an infinite set of coupled differential equations for the
probabilities of all possible events. In comparison to similar
equations for SIS models, Eqs. (9) and (11) are still relatively
complex and cannot be solved explicitly in a closed form. To
resolve this problem, we note that in many applications, virus
kinetics and kinetics of living cells are characterized by different
time scales, namely, a single virus particle, when it is not inside an
infected cell, is cleared from the body on a much faster timescale
than the lifetime of an infected cell [1,2,4]. To be able to
propagate, virus should multiply in large numbers (N.1) and
infect cells as quickly as possible. Thus virus dynamics can often be
considered fast in comparison with infected cell dynamics.
The approach of using such a time-scale separation in the
semiclassical equations was developed previously [20,21]. The idea is
that fast degrees of freedom can be considered equilibrated at current
values of slow variables, so that time-derivatives in Eq. (12) of the fast
variables can be set to zero. The approach is commonly used in viral
dynamic modeling and in that field is called a quasi-steady state
assumption [32]. In particular, considering virus clearance to be fast,
we can eliminate the virus-related variables by setting.
LH
LxV
~0,
LH
LnV
~0: ð13Þ
This reduces some of the differential equations to algebraic
equations that can be solved explicitly, i.e., from Eq. (13) we obtain
Spontaneous Infection Clearance
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the elimination of the fast dynamics of the virus,
nV~
kTexIzc ðÞ NdnI
kTzc ðÞ
2 , xV~ln
kTexIzc
kTzc
  
: ð14Þ
We then substitute this result back into the expression for the
Hamiltonian and obtain the effective Hamiltonian that describes the
lower-dimensional evolution of slow variables only. For Model 1,
the effective Hamiltonian reduces to.
H
eff
1 nI,xI ðÞ ~nI
kTNd
kTzc
exI{1 ðÞ znId e{xI{1 ðÞ : ð15Þ
According to Eq. (15) and rules 2a-2b, Model 1 reduces to a
previously extensively studied SIS model as shown in Figure 1(b) in
which an infected cell either produces one more infected cell or
dies, and both processes are exponentially distributed with time, as
we illustrate in Figure 2(a). For this SIS model shown in Figure 1(b),
one can write the master equation which can be solved exactly for
the mean and variance using the generating function technique.
These results can be used further to make estimates of the key rate
parameters from experimental data that describe the primary
phase of a viral infection even for a single sample as shown in Text
S2 and Figure S1.
The effective Hamiltonian for Model 2 with a Poisson
distribution of burst sizes, Eq. (11), after elimination of the fast
viral degrees of freedom is given by.
H
eff
2 nI,xI ðÞ ~nId e
{xIz kTN
kTzc exI {1 ðÞ {1
  
: ð16Þ
The form of H2
eff in Eq. (16) corresponds to the decay of
infected cells with rate nId, which when this happens, leads to an
elimination of one infected cell and creation of a burst of new
infected cells. Actually, Eq. (16) corresponds to the process, in
which there is a burst release of free viruses which then either
quickly decay or infect new cells. The number of newly infected
cells per burst has Poisson statistics. Hence, a branching stochastic
process Model 2 is reduced to an effective one as described in
Figure 1(e). If a fixed burst size is assumed then starting from Eq.
(10) after eliminating fast variables one obtains.
H
eff
2 fixedN ðÞ ~dnI e{xI kTexIzc
kTzc
   N
{1
 !
ð17Þ
The two Hamiltonians, H1
eff and H2
eff describe evolutions of the
number of infected cells in Models 1 and 2. The different forms of
H1
eff and H2
eff mean that the behavior of fluctuations in the two
models is very different. Nevertheless, the Hamiltonians, H1
eff and
H2
eff, lead to essentially the same type of behavior for the mean
number of infected cells. It is well known that the equation for an
average quantity is given by [16,17,18,31]:
S_ n nIT~
LH
LxI
DxI~0 ð18Þ
Then, for constant parameters, Eqs. (15), (16) and (17) all
predict that.
SnIT~nI 0 ðÞ exp d
kTN
kTzc
{1
  
t
  
: ð19Þ
In this section, we showed that using the coarse graining
approach [20,21] it is possible to reduce the complexity of models
of viral infections. The resulting Hamiltonian dynamics can be
analyzed with the same approach as in previously studied SI
models (see Text S3, Figure S2, for a model that includes
susceptible cells, i.e. target cells, in addition to virions and infected
cells).
Effective Hamiltonians can be used further to study infection
kinetics on a coarse-grained level. For illustration, we will consider
both models as examples and use the coarse graining technique to
calculate disease extinction time.
Spontaneous Infection Clearance
The extinction of a disease occurs along a trajectory in the
phase space of the classical Hamiltonian known as the optimal
path trajectory [33]. The probability of disease extinction
decreases exponentially with increasing population size. The
mean extinction time of the disease along the Hamiltonian
trajectories that start from the metastable state and end at the
extinction state where the number of infected cells reaches zero
has the form.
t~s{1 exp {S ðÞ , ð20Þ
where S is known as action in classical physics [31]. A precise
estimation of the prefactor s can be a hard task because it is
influenced by the non-semiclassical and geometric phase correc-
tions to our approximations. Its precise value is, however, not
important because Eq. (20) is dominated by the exponent. Using
arguments in Reference [13] one can estimate that s ed.
As was discussed earlier, disease extinction is a rare event. Due
to an unusually strong fluctuation the system can jump from its
equilibrium metastable state to the extinction state along an
optimal path that minimizes the action S. The optimal Hamilto-
nian trajectory that describes S starts from the metastable state and
ends at the extinction state. Since the probability of extinction is
found by minimizing the action, we compute such trajectories
satisfying the zero energy condition, i.e., H=0, as discussed in
Reference [13]. This strongly simplifies further calculations
because virus degrees of freedom are already eliminated, and
one does not have to solve Hamiltonian equations explicitly.
Instead, from H=0, one can find how nI depends on xI along this
trajectory and then the action has the form.
S~{
ð 0
  n nI
xI nI ðÞ dnI~
ð
xI nI~0 ðÞ
xI nI~  n nI ðÞ
nI xI ðÞ dxI, ð21Þ
where   n nIis the number of infected cells in the steady state.
At the metastable state, the average number of infected cells is
given by.
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dt
~
LH
LxI
DxI~0~0, ð22Þ
such that SnIT~  n nI
Consider the problem of spontaneous infection clearance from
the metastable state in Model 1 and Model 2.
We first assume a finite well-mixed population of virions and
cells such that kT~k’1 Nt{nI ðÞ , where k’1 is a constant, and Nt is
the total number of cells.
Model 1
Following the above methodology, the number of infected cells
in the steady state for Model 1 is.
  n nI~Nt{
c
k’1 N{1 ðÞ
: ð23Þ
Using the relation kT~k’1 Nt{nI ðÞ and equating the effective
Hamiltonian for Model 1 to zero we get the following algebraic
equation for the number of infected cells.
nI xI ðÞ ~Nt{
c
k’1 NexI{1 ðÞ
, ð24Þ
where xI nI~  n nI ðÞ ~0 and xI nI~0 ðÞ ~ln
czk’1Nt
Nk’1Nt
  
: Substi-
tuting Eq. (24) into Eq. (21) one can calculate the action S and
from it the mean extinction time according to Eq. (20).
S~
cln cN
N{1 ðÞ czk’INt ðÞ
  
zk’INt ln
Ntk’IN
czk’INt ðÞ
  
k’I
: ð25Þ
Model 2
Similarly, following Eq. (22).
  n nI~Nt{
c
k’1 N{1 ðÞ
: ð26Þ
Again equating the Hamiltonian for Model 2 to zero yields.
nI xI ðÞ ~Ntz
cxI
k’1 xIzN 1{exI ðÞ ðÞ
: ð27Þ
Substituting this into Eq. (21), S can be computed numerically.
Figure 3(a) shows the numerically computed mean extinction
time t as a function of Nt for both of these models with parameter
values applicable to HIV dynamics. While the two models predict
quantitatively different exponents, qualitatively they lead to similar
conclusions at realistic parameter values. For a total population of
around 70 to 80 cells in an isolated region, one is likely to see
spontaneous infection clearance within several days. As a practical
matter spontaneous extinction can take place only up to a critical
cell number. As Nt increases further, the extinction times become
so large that they become unreachable, suggesting that the
infection cannot be cleared spontaneously at those conditions.
From Eq. (24) or (27) one can compute that for the parameters
used in Fig. 3, when Nt=80, the number of infected cells is about
11. Thus spontaneous clearance in a few days would only be
expected to occur in small foci of infected cells of order 10 or less
as shown in Figure 3(b). Further, as one can see from the figure
spontaneous clearance is more rapid when virus production is
continuous (model 1) than when it occurs in bursts (model 2).
Let us now switch to the case for which kT~ k’1
Nt Nt{nI ðÞ . One
can calculate the mean extinction time for both the models using
the same methodology as above:
Model 1
  n nI ~Nt{
cNt
k’1 N{1 ðÞ
: ð28Þ
nI xI ðÞ ~Nt{
cNt
k’1 NexI{1 ðÞ
, ð29Þ
wherexI nI~0 ðÞ ~ln czk’1
Nk’1
  
and xI nI~  n nI ðÞ ~0:
S~Nt ln
cNt
k’1 N{1 ðÞ
  
z
Nt czk’1 ðÞ
k’1
ln
cN
czk’1 ðÞ N{1 ðÞ
  
ð30Þ
Model 2
Using Eq. (22) and equating the Hamiltonian in Eq. (16) to zero,
we get.
  n nI~Nt{
cNt
k’1 N{1 ðÞ
ð31Þ
nI xI ðÞ ~Ntz
cxINt
k’1 xIzN 1{exI ðÞ ðÞ
: ð32Þ
The action S can then be calculated numerically using the above
set of equations.
From the action, S, one can numerically calculate the mean
extinction time, t, as a function of Nt, this time, in the context of
HCV dynamics where kT~
k’1
Nt
Nt{nI ðÞ . Unlike HIV and HBV,
HCV is a chronic infection that can be cured in patients by
antiviral therapy [2,34]. Spontaneous clearance of HCV infection
has also been reported, both in the absence and presence of HCV-
specific cellular immune responses [11,26,35], and our theory can
make predictions about the size of regions in the liver that can be
cleared spontaneously. It has been estimated that in the absence of
treatment about 5%–20% of hepatocytes (liver cells) are infected
during chronic HCV infection [36,37]. Taking the geometric
mean of these estimates, we shall assume 10% of hepatocytes in
any region of the liver are infected. Further, as done by Rong et al.
[34], we assume that due to different states of differentiation or
due to some cells being in an interferon-induced ‘‘antiviral state’’
only about 50% of hepatocytes are targets of HCV infection at any
time (i.e., Nt is about 50% of hepatocytes in any region being
considered and hence k’1~kT=0:8). Then using previously
Spontaneous Infection Clearance
PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e38549estimated parameter values characterizing HCV infection, c=6.2
day
21, d=0.14 day
21, N=336, kT= c=N[34], we find
k’1 =0.023 days
21. Figure 4(a) shows the numerically calculated
mean extinction time, t, as a function of Nt for models 1 and 2. We
predict for models 1 and 2, for regions of the liver that contain
around 170 and 85 susceptible hepatocytes (Figure 4(a)) or around
380 and 170 total hepatocytes, respectively, infection can be
cleared spontaneously within a year. If Nt .170 for model 1 and Nt
.85 for model 2, spontaneous infection clearance becomes
practically impossible. With 10% of the total hepatocytes being
infected, for model 1 and 2, within a year, one is likely to see
spontaneous infection clearance in a small region with around 35
or 17 infected cells respectively (Figure 4(b)). It is also seen from
Figure 4(b) that 10 or fewer infected cells are removed from the
human liver spontaneously in about 20 days, while for HIV
infection 10 infected cells can be spontaneously cleared in about 4
days (Figure 3(b)). Also, as in the case of HIV, clearance is more
rapid in model 1 than in model 2. Also, for HCV continuous
production model (model 1) is probably more biologically realistic
than burst production as there is little evidence to suggest that the
virus kills infected cells in vivo.
Ordinary differential equation models of HCV infection and
treatment have shown that there is a critical drug effectiveness, ec,
such that if the drug effectiveness, e, is below ec, the HCV viral
load goes to a new on therapy steady state in which the HCV level
is lower than in the pre-treatment steady state [38]. The drug
effectiveness can be below its critical value when therapy is
suboptimal as appears to be the case in the approximately 50% of
people who do not clear HCV with interferon-based therapy. In
addition, e may be less than ec in regions of the liver where drugs
do not reach properly or in the presence of drug resistant HCV
variants. Our calculations suggest that viral clearance may still
occur when evecdue to spontaneous fluctuations. The closer e is
to ec, the lower the on therapy viral load and the more likely
spontaneous fluctuations can clear the infection. We note,
however, that the presence of such regions in HCV infected liver
in which clearance is spontaneous remains a hypothesis.
We also make an observation that the exponent, S, in Eq. (20)
for the mean time to clearance is independent of the parameter d,
which represents the infected cell death rate. One can show that
the latter rate only enters the prefactor of the exponent, s~ d d. Thus
the kinetics of infection clearance is not very sensitive to this rate.
Physically this means that infection clearance is not exponentially
sensitive to the average lifetime of an infected cell. In contrast, we
found that the infection lifetime is exponentially sensitive to the
parameters k’1, N and c, all of which describe virus kinetics.
Discussion
We have developed a theory based on a mixed computational/
theoretical approach to analyze stochastic events in the course of a
viral infection. This method has been applied earlier to stochastic
biochemical networks, such as enzymatic reactions, characterized
by slow non- Poissonian fluctuations [20].
We explored two previously introduced models of viral infection
that involve either continuous or burst production of virus from
infected cells and used the coarse-grained semi-classical treatment
to capture various aspects of the corresponding stochastic
dynamics. During any viral infection, from HIV to the common
cold, it is important to know whether the infection goes extinct or
becomes persistent. We predicted the mean time for infection
clearance in both our models and showed that this extinction time
is sensitive to virus related parameters such as the virion clearance
rate and the virion infectivity. On the other hand, the extinction
time is not exponentially sensitive to the lifetime of an infected cell.
This is in contrast to deterministic evolution models, in which all
kinetic rate parameters are usually equally important and the time
to eliminate an infection by therapy is more sensitive to the lifetime
of an infected cell than other parameters [39]. Thus, if drug
therapy fails to clear an infection and leaves foci of infected cells in
tissues, as has been suggested for both HIV and HCV [13,40],
then intensifying therapy by adding a drug that reduces infection
would seem to be a better strategy that adding an immune
modulator that could increase the rate of infected cell death.
Figure 3. Numerically computed mean extinction time t, (a) as a function of Nt, inset shows the extinction time at higher values
of Nt (b) as a function of nI, solid line: Model 1 and dashed line: Model 2, kT~k’1 Nt{nI ðÞ , N=30, c=20 day
21, d=1 day
21 and
k0
1 =0.01 cell
21 day
21.
doi:10.1371/journal.pone.0038549.g003
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number of cells in a finite population that can be cleared
spontaneously leading to disease extinction. For parameters
relevant to HIV infection, as used here, we showed that
spontaneous clearance is only likely to occur in small cell
populations, i.e., a population of less than 100 cells (Figure 3(a)).
Thus, once infection is established throughout the body, sponta-
neous extinction is predicted not to occur, consistent with the
observation that essentially no one infected with HIV has
spontaneously cleared the infection. Nonetheless, the theory
predicts that if small isolated clusters of infected T cells exist,
infection could spontaneously die out in individual clusters. Note
the simple theory presented here, ignores the complications of
latently infected cells [41] and long-lived infected cells [42], the
existence of which reduce the probability of extinction. However,
our theoretical method can be straightforwardly generalized and
applied to more complex interacting stochastic processes, such as
those involving these additional cell populations, as well as
situations in which neither the number of target cells nor the
total number of cells are assumed to be constant.
In the case of HCV infection, the assumption of a constant total
number of cells, susceptible plus infected, has been made
previously and seems reasonable as this virus, unlike HIV, usually
does not kill the cells it infects. Further, unlike HIV, spontaneous
clearance of infection has been frequently observed [6] and in
some cases even in the absence of a strong immune response [11].
For parameters relevant to HCV infection, we showed that
spontaneous clearance can occur in infected cell populations of the
order of 40 infected cells or less in a region of the human liver,
based on predictions of the continuous production model
(Figure 4(b)). It is unclear if current drug therapy completely
clears HCV infection or simply reduces the amount of virus and
number of infected cells to a low level, with the ultimate clearance
then being immune mediated or occurring spontaneously due to
stochastic fluctuations, as in our model [40]. However, more
elaborate models that incorporate immune defenses would be
valuable to pursue in the context of the stochastic modeling
approach presented here.
Supporting Information
Figure S1 The logarithm of nI(t)/nI(0) as a function of time t.
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